As an M&A professional, here’s why this is a prime opportunity: • The market: Mental health & substance abuse treatment • The target: Dual-diagnosis outpatient programs • The plan: Scale and optimize Let’s break it down: The Market Mental health & addiction recovery is a multi-billion-dollar industry, and demand is only increasing. This Arizona-based facility combines outpatient treatment with sober living programs, offering long-term sobriety solutions. Revenue? $4.93M (2023/24 avg). But that’s not the most interesting part. 👇 The BusinessFounded in 2016, this facility built its reputation on: • Customized treatment plans • A dual-diagnosis approach (addiction + mental health) • High retention: Nearly 100% of patients choose their sober living housing With proprietary methods and a new VA contract, they’re poised for massive growth. The Numbers 💵 Revenue: $4.93M (2023/24 avg) 💰 Earnings (SDE): $1.8M (2023/24 avg) 📈 Asking Price: $8M 🔗 Multiple: 4.4x Post-COVID, they resolved billing inefficiencies, added a new residential facility, and are back on track for steady growth. Growth Potential This business has untapped opportunities: 1️⃣ Expand into detox & residential programs (higher revenue/patient) 2️⃣ Reintroduce evening outpatient care 3️⃣ Leverage TriWest VA contract for massive patient access 4️⃣ Boost marketing with a mix of digital + boots-on-ground Challenges 📉 Past billing inefficiencies impacted financials (now resolved). 👥 Growth depends on execution of new VA contract. 💻 Marketing underleveraged—great opportunity for the next owner. But these are solvable with the right systems and strategy. The OpportunityThis isn’t just a business; it’s a chance to make an impact. With the foundation already built, there’s huge upside: • SBA loan eligible (up to $5M) • Staff handles daily operations—owners are hands-off • Scalable model with room for innovation My Take as an AnalystThis deal is a rare find in healthcare M&A: ✔ Fair valuation at 4.4x multiple